Patient Guide: A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 74 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05748171
Status: 🟢 Enrolling Now
Condition: ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2

Where You Can Participate

This study is available at 74 locations across the country.

Top locations include:
  • • Vienna,
  • • Brussels, Bruxelles-capitale, Région DE
  • • Gent, Oost-vlaanderen
  • • And 71 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL - Join Clinical Trial NCTNCT05748171

How to Join This Clinical Trial - NCTNCT05748171

Learn how to participate in this PHASE2 trial studying an investigational therapy for ACUTE LYMPHOBLASTIC LEUKEMIA. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with ACUTE LYMPHOBLASTIC LEUKEMIA. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
ACUTE LYMPHOBLASTIC LEUKEMIA
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT05748171 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 74 locations. Find a study site near you:

Clinical Research Site

Vienna, 1090 - Austria

Status: RECRUITING

Clinical Research Site

Brussels, Bruxelles-capitale, Région DE 1200 - Belgium

Status: RECRUITING

Clinical Research Site

Gent, Oost-vlaanderen 9000 - Belgium

Status: RECRUITING

Clinical Research Site

Leuven, Vlaams-brabant 3000 - Belgium

Status: RECRUITING

Clinical Research Site

Brno, Brno-město 613 00 - Czechia

Status: RECRUITING

Clinical Research Site

Prague, 150 06 - Czechia

Status: RECRUITING

Clinical Research Site

Copenhagen, Hovedstaden DK-2100 - Denmark

Status: RECRUITING

Clinical Research Site

Helsinki, 00290 - Finland

Status: RECRUITING

Clinical Research Site

Nice, Alpes-maritimes 06202 - France

Status: RECRUITING

Clinical Research Site

Strasbourg, Alsace 67098 - France

Status: RECRUITING

And 64 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for ACUTE LYMPHOBLASTIC LEUKEMIA:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships